So we proposed the following schematic diagram to help illustrate these mechanisms in which ZHX2 participates in ccRCC development (Fig. 6h) and ultimately serves as a potential therapeutic target. This evidence concerns the gene ZHX2 and nonpapillary renal cell carcinoma.